HistoSonics’ unique new platform technology has the potential to fundamentally change the nature of cancer therapy. RAST uses histotripsy and the mechanical properties of focused ultrasound to destroy targeted tissues without damaging surrounding tissue or structures. This non-invasive, non-thermal treatment can be used to safely, precisely and effectively destroy unwanted tissue throughout the body, reducing patient trauma and healthcare costs.
3526 W Liberty Rd #100, Ann Arbor, MI 48103
CEO: Mr. Mike Blue